- Trials with a EudraCT protocol (176)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
176 result(s) found for: Sodium MRI.
Displaying page 3 of 9.
EudraCT Number: 2017-005144-14 | Sponsor Protocol Number: 01-CARDIONIDO | Start Date*: 2018-04-12 |
Sponsor Name:Dr. Forteza Gil | ||
Full Title: Comparative study of two types of cardioplegia during cardiac surgery in the adult patient | ||
Medical condition: Cardiac surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001369-28 | Sponsor Protocol Number: 880 | Start Date*: 2014-10-30 | |||||||||||
Sponsor Name:Gateshead Health NHS Foundation Trust | |||||||||||||
Full Title: THYRoxine in Acute Myocardial Infarction (ThyrAMI) | |||||||||||||
Medical condition: Hypothyroidism and Acute Myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003046-13 | Sponsor Protocol Number: 2021/ABM/03/00008 | Start Date*: 2023-11-27 | |||||||||||
Sponsor Name:Śląskie Centrum Chorób Serca | |||||||||||||
Full Title: Sacubitril/Valsartan in PriMAry preventIoN of the cardiotoxicity of systematic breaST canceR trEAtMent. Randomized, multicenter, double-blind, placebo-controlled study. | |||||||||||||
Medical condition: Heart failure – post-anthracycline cardiomyopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002766-39 | Sponsor Protocol Number: ET13-002 | Start Date*: 2021-02-17 | |||||||||||
Sponsor Name:Centre Leon Berard | |||||||||||||
Full Title: SIOP Ependymoma II - An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with Ependymoma | |||||||||||||
Medical condition: Newly diagnosed with an intracranial or spinal ependymoma (all WHO grades) including ependymoma variants: cellular, papillary, myxopapillary, clear-cell and tanycytic) or anaplastic ependymoma. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) IE (Trial now transitioned) IT (Trial now transitioned) BE (Trial now transitioned) ES (Ongoing) NO (Trial now transitioned) DE (Trial now transitioned) FR (Trial now transitioned) DK (Trial now transitioned) FI (Trial now transitioned) CZ (Trial now transitioned) AT (Trial now transitioned) NL (Trial now transitioned) GR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001710-37 | Sponsor Protocol Number: NL73727 | Start Date*: 2021-05-26 |
Sponsor Name:Academisch Medisch Centrum | ||
Full Title: Intravenous immunoglobulin and prednisone vs. prednisone in newly diagnosed myositis: a double blind randomized clinical trial. | ||
Medical condition: idiopathic inflammatory myopathies | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001455-37 | Sponsor Protocol Number: 1331TMF | Start Date*: 2011-12-21 | |||||||||||
Sponsor Name:Department of Radiology, Oslo University Hospital, Norway | |||||||||||||
Full Title: Prospective randomized interventional study. Compare the effect of bleomycin and Tetradecyl Sodium Sulphate (Fibrovein) in the treatment of venous malformations. Clinical neurological and neurophys... | |||||||||||||
Medical condition: Venous malformation | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021879-85 | Sponsor Protocol Number: 10050 | Start Date*: 2010-09-08 |
Sponsor Name:University of Nottingham | ||
Full Title: Mode of action of Moviprep:impact on distribution of intestinal fluid and colonic microbiota | ||
Medical condition: for bowel cleansing prior to any clinical procedure requiring a clean bowel, e.g, bowel endoscopy, lower gastrointestinal tract radiology or digestive tract surgery. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-003197-13 | Sponsor Protocol Number: ISIS484137-CS2 | Start Date*: 2017-11-24 | ||||||||||||||||
Sponsor Name:Ionis Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Pharmacodynamics of ISIS 484137 (ISIS-DGAT2RX, an Antisense Inhibitor of Diacylglycerol Acyltr... | ||||||||||||||||||
Medical condition: Hepatic Steatosis in type 2 diabetes (T2DM) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-002003-33 | Sponsor Protocol Number: EQ06.17.01 | Start Date*: 2018-12-12 | |||||||||||
Sponsor Name:FIDIA FARMACEUTICI S.P.A. | |||||||||||||
Full Title: A double blind, double dummy, multicenter, randomized, placebo- and active-controlled clinical trial to evaluate effectiveness of Tricortin 1000 in patients affected by chronic low back pain | |||||||||||||
Medical condition: Low Back Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003575-21 | Sponsor Protocol Number: | Start Date*: 2017-07-25 | |||||||||||
Sponsor Name:MRC Clinical Trials Unit at UCL | |||||||||||||
Full Title: A multicentre, 48 week randomised controlled factorial trial of adding maraviroc and/or metformin for hepatic steatosis in HIV-1-infected adults on combination antiretroviral therapy. | |||||||||||||
Medical condition: Hepatic steatosis in adults with chronic HIV-1 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003296-36 | Sponsor Protocol Number: C0524T06 | Start Date*: 2006-03-29 |
Sponsor Name:Centocor B.V. | ||
Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Rheumatoid Arthr... | ||
Medical condition: Active rheumatoid arthritis (RA) despite methotrexate (MTX) therapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-012989-30 | Sponsor Protocol Number: MS-LAQ-301E | Start Date*: 2009-11-17 | |||||||||||
Sponsor Name:Teva Pharmaceutical Industries Ltd | |||||||||||||
Full Title: A multinational, multicenter, open-label, single-assignment extension of the MS-LAQ-301 (ALLEGRO) study, to evaluate the long-term safety, tolerability and effect on disease course of daily oral la... | |||||||||||||
Medical condition: Laquinimod is developed for the treatment of relapsing remitting multiple sclerosis. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) NL (Prematurely Ended) EE (Prematurely Ended) ES (Prematurely Ended) HU (Prematurely Ended) DE (Prematurely Ended) CZ (Prematurely Ended) IT (Prematurely Ended) FR (Completed) LT (Prematurely Ended) AT (Prematurely Ended) SE (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000752-18 | Sponsor Protocol Number: 17-924 | Start Date*: 2019-02-19 |
Sponsor Name:UMC Utrecht | ||
Full Title: Ajmaline provocation in asymptomatic PLN and PKP2 mutation carriers for early detection of Arrhythmogenic Cardiomyopathy | ||
Medical condition: Arrhythmogenic cardiomyopathie due to PLN or PKP2 mutations, asymptomatic family members who are carriers of PLN or PKp2 mutations, patients without structural heart disease who are referred for aj... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001158-33 | Sponsor Protocol Number: OZR-2016-34 | Start Date*: 2017-07-20 |
Sponsor Name:The Rotterdam Eye Hospital | ||
Full Title: A pilot study towards a therapy with prednisolone encapsulated liposomes for the treatment of Graves’ Orbitopathy with reduced systemic steroid exposure | ||
Medical condition: Graves' Orbitopathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000148-24 | Sponsor Protocol Number: 1 | Start Date*: 2018-06-14 |
Sponsor Name:Norwegian University of Science and Technology | ||
Full Title: Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer’s disease: the ExPlas Study | ||
Medical condition: Early Alzheimer's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003505-26 | Sponsor Protocol Number: TOHNER/31 | Start Date*: 2019-03-18 | |||||||||||
Sponsor Name:ABIOGEN PHARMA S.P.A. | |||||||||||||
Full Title: Randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of treatment with Neridronate 100 mg (4 infusions over a period of 10 days) in patients with tra... | |||||||||||||
Medical condition: Transient osteoporosis of the hip. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003232-21 | Sponsor Protocol Number: C0524T12 | Start Date*: 2006-12-11 |
Sponsor Name:Centocor B.V. | ||
Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Intravenously, in Subjects with Active Rheumatoid Arthri... | ||
Medical condition: Rheumatoid Arthritis (RA) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) HU (Completed) LV (Completed) LT (Completed) MT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002257-76 | Sponsor Protocol Number: 3074K5-319-WW | Start Date*: 2006-12-20 | |||||||||||
Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Comparison Study of the Safety and Efficacy of a Once-Daily Dose of Tigecycline versus Ertapenem for the Treatment of Foot Infections in Subjects with Diabetes | |||||||||||||
Medical condition: Subjects with diabetes with a qualifying foot infection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) SE (Prematurely Ended) LT (Completed) SK (Completed) FI (Completed) GB (Completed) LV (Completed) PT (Completed) EE (Completed) FR (Completed) AT (Completed) GR (Completed) DE (Completed) IT (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004594-43 | Sponsor Protocol Number: ISTEM02 | Start Date*: 2021-05-27 | |||||||||||
Sponsor Name:CECS/I-Stem | |||||||||||||
Full Title: AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation | |||||||||||||
Medical condition: Wolfram syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002551-11 | Sponsor Protocol Number: HP-CKDPKD | Start Date*: 2022-01-18 | ||||||||||||||||
Sponsor Name:Aarhus University | ||||||||||||||||||
Full Title: Chronic kidney disease – imaging the metabolic derangements with ultra-sensitive MRI | ||||||||||||||||||
Medical condition: Chronic kidney disease and polycystic kidney disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
